Bharat Biotech successfully concludes phase 3 clinical trial of its oral cholera vaccine “hillchol”, proving its immunogenic response against cholera and paving the way for successful launch in the market.
1 Like
Thats great news and a great step forward! An effective oral cholera vaccine like Hillchol could really improve public health, especially in vulnerable areas.
2 Likes
Great News, we can see the Sun of new pharmaceutical industry rising.
2 Likes
Wow!
1 Like